Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Foresite Capital in the transaction. Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.) (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company,...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented AtaCor Medical in the transaction. AtaCor Medical (“Atacor”) announced it raised $28 million in Series C financing round...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP and Gross & Co. advised Ukko on the deal. Ukko, a biotech company with the mission to eliminate...
You must be a Standard 1 Year member to access this content.
